The microscopic O&P results section will now contain an extensive list of positive and negative findings.The GI Effects 22 will include 6 PCR targets (replacing EIA) that detect common protozoan parasites: If you have questions regarding what it means for your patients, please contact us at +44 (0)20 8336 7753 to speak with one of our Client Services Representatives.īeginning January 21, 2019, Genova will offer the addition of PCR parasites to the GI Effects Comprehensive #2200, GI Effects Microbial Ecology Profile #2205, and as part of a brand new Gut Pathogen Profile #2207. Add-ons available: Clostridium difficile, Campylobacter spp., Shiga toxin Escherichia coli, Helicobacter pylori stool antigen.Microscopic O&P, including an extensive list of positive and negative findings.6 PCR targets including Blastocystis subtyping 1-9.This profile provides a comprehensive evaluation of organisms known to contribute to common GI symptoms including: Add-on markers are consolidated into fewer pagesĭownload GI Effects Comprehensive Sample ReportĪdditionally, this PCR technology is part of a brand new Gut Pathogen Profile.Commensal and Biomarker Clinical Association Charts have been moved to the end of the report.The microscopic O&P results section now contains an extensive list of positive and negative findings.The GI Effects upgrade also includes several ease of use report enhancements: The GI Effects 22 now include 6 PCR targets (replacing EIA) that detect common protozoan parasites: Genova is NOW OFFERING the addition of PCR parasites to the GI Effects Comprehensive #2200, GI Effects Microbial Ecology Profile #2205, and as part of a brand new Gut Pathogen Profile #2207.

Genova diagnostics sibo test